USPTO serial 79378897
PXB-SHIZUKU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- SEVERSON, JUSTIN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PXB-SHIZUKU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey H. Handelsman
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; biological preparations, other than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research use, other than for medical or veterinary purposes; cell culture medium for scientific or research use, other than for medical or veterinary use; cell culture conditioned medium for scientific or research use, other than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research use, other than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research use, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PhoenixBio Co., Ltd.
- Other trademarks owned by PhoenixBio Co., Ltd.
- Other trademarks owned by PhoenixBio Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named PXB-SHIZUKU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 28, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 28, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 12, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 8, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 29, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 29, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 29, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 29, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 29, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 17, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 28, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 27, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 19, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 15, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |